Imricor Medical Systems (ASX:IMR) said Semmelweis University's Heart and Vascular Center in Hungary performed its first atrial flutter ablations guided by real-time magnetic resonance imaging, through the company's NorthStar 3D mapping system, according to a Thursday filing with the Australian bourse.
The company aims for continued expansion and growth across Europe, including adding more sites to the VISABL-VT clinical trial, the filing said.
Imricor Medical Systems shares rose past 2% in morning trade Thursday.
Price (AUD): $1.66, Change: $+0.040, Percent Change: +2.47%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。